Active ingredients: foscarnet
What it is used for
Treatment of cytomegalovirus (CMV) retinitis in patients with the acquired immunodeficiency syndrome (AIDS). INDICATIONS AS AT 11 NOVEMBER 1994: For treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS); and treatment of aciclovir resistant herpes simplex virus (HSV) infections (defined by clinical trial or in-vitro resistance) in immunocompromised patients with human immunodeficiency virus (HIV) infection. NOTE: the indication for treatment of aciclovir resistant HSV infections in immunocompromised patients with HIV infections is based primarily on the results of one open label comparative study. This was of patients with HIV infections and herpetic lesions unresponsive to aciclovir administered intravenously for 10 days or more and in-vitro documented resistance to aciclovir. Eight patients were randomised to foscarnet (40mg/kg IV given eight hourly) and 6 were randomised to vidarabine 15mg/kg IV daily. The results showed a significant difference in favour of the foscarnet treatment group for clinical and virological endpoints, especially in time to complete healing of lesions and time to complete loss of pain. In 177 other patients treated with foscarnet in non-comparative studies, results were sufficiently similar to support the efficacy of foscarnet in this indication.
How to take it
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 30 degrees Celsius
- Do not Refrigerate
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
A clear colourless solution.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient foscarnet
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems